MCHX, US56624R1086

Marchex stock (US56624R1086): Q1 earnings and Archenia acquisition boost guidance

14.05.2026 - 14:46:00 | ad-hoc-news.de

Marchex raised Q2 adjusted EBITDA guidance and outlined plans to acquire Archenia, potentially expanding into AI-driven vertical markets with a combined revenue run-rate of $15 million quarterly.

MCHX, US56624R1086
MCHX, US56624R1086

Marchex announced first-quarter 2026 results on May 13, 2026, alongside an update on its planned acquisition of Archenia, signaling confidence in near-term profitability and longer-term growth prospects. The company raised its Q2 adjusted EBITDA guidance to $1.6 million to $1.8 million, up from prior guidance of more than $1 million, according to BusinessWire as of May 13, 2026.

As of: May 14, 2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Marchex, Inc
  • Sector/industry: AI-powered conversation intelligence and call analytics
  • Headquarters/country: United States
  • Core markets: B2B2C verticals including automotive, healthcare, and financial services
  • Key revenue drivers: Call tracking, conversational analytics, performance marketing solutions
  • Home exchange/listing venue: Nasdaq (MCHX)
  • Trading currency: USD
  • Market capitalization: Approximately $70.88 million

Marchex: core business model

Marchex operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company's core services include call tracking, conversational analytics, and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies, and brands to gain actionable insights into caller intent, marketing return on investment, and customer behavior. Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting, and AI-driven transcription to surface trends and conversion signals from inbound calls.

Q1 results and forward guidance

The company raised its adjusted EBITDA outlook to a range of $1.6 million to $1.8 million for Q2 2026, reflecting improved operational efficiency and revenue growth expectations. Management indicated that revenue should rise sequentially in Q2, with further improvement possible in Q3 if the Archenia acquisition closes as planned, according to MarketBeat as of May 13, 2026. The company also noted that higher cash generation would provide flexibility as it evaluates the best use of capital.

Archenia acquisition and growth strategy

Marchex outlined its planned acquisition of Archenia, which could expand the company into a vertically focused AI-driven platform. The potential combined company's revenue run-rate would be approximately $15 million quarterly, or about $60 million annualized, with 15% to 20% growth expected in 2026. This transaction represents a significant strategic shift toward vertical market specialization and AI-enhanced analytics capabilities, positioning Marchex to serve market-leading companies in B2B2C segments more comprehensively.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Marchex's raised guidance and Archenia acquisition announcement reflect management confidence in near-term profitability and medium-term growth. The combination of improved EBITDA expectations and a strategic acquisition targeting vertical market expansion signals a shift toward higher-margin, AI-driven solutions. For US investors tracking small-cap software and analytics companies, Marchex's progress on profitability and strategic positioning warrant monitoring as the Archenia transaction progresses.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis MCHX Aktien ein!

<b>So schätzen die Börsenprofis  MCHX Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US56624R1086 | MCHX | boerse | 69334129 |